New Ubiquitinated Inclusion Body Protein Identified
Ubiquitin-positive protein inclusions are a hallmark of frontotemporal dementias and other neurodegenerative diseases...
ALL NEWS
5787 RESULTS
Sort By:
- Most Recent
- Most Commented
GDNF Powers Neuron Sprouting in Human Brain
For the first time, researchers have witnessed dopaminergic neuron sprouting in a Parkinson disease (PD) patient treated with...
Huntingtin, BDNF, Neurodegeneration: Is Speed of the Essence?
In today's Cell, researchers report that huntingtin (htt) enhances transport of brain-derived neurotrophic factor (BDNF) along microtubules...
Axonal Transport Not Bothered by Tau Elevation In Vivo
Elevations in tau levels, and/or changes in its cellular distribution, disrupt microtubule function and axonal transport...
Medical Foods—Fallback Option for Elusive AD Drug Status?
Defined by the FDA in 1988, medical foods are a special class of therapeutic agent that fall somewhere in between unregulated food supplements and FDA-approved drugs...
Brief: NFL Survey on Dementia Splashes Across Front Pages
Today’s news media are abuzz with reports, and the blogosphere with opinion, about a new phone survey on dementia commissioned by the National Football League...
Brain Aβ Patterns Linked to Brain Energy Metabolism
What makes some areas of the brain more vulnerable to Aβ? A pair of related papers offer a clue...
Longevity Tied to Insulin Action in Brain
The search for the fountain of youth did not end with Ponce de Leon. Rather...
San Diego: TDP-43 Targets Loom Large—But Where’s the Bull’s Eye?
If posters at the Society for Neuroscience (SfN) meeting and a recent publication are any indication, the field is poised to discover a wealth of clues to TDP-43 function...
Sirtuin Inhibitor Boosts Cognition, Reduces Phospho-tau
Scientists blocked the activity of sirtuins and found that this inhibition restored cognition in a mouse model for AD...
Paper Alert: Do Blood-Borne Factors Control Brain Aging?
Today in Nature, researchers confirm what has been playfully called the “vampire principle”...
Abnormal Mitochondrial Dynamics—Early Event in AD, PD?
Mitochondria take the stage in three recent papers...
Paper Alert—Phase 3 Tarenflurbil Data Published
Tarenflurbil, aka flurizan, a γ-secretase modulator that showed promise in early preclinical and clinical trials, failed in Phase 3...
A Better GRIP on the Aβ-Lipid Connection
In a provocative paper, researchers led by Tobias Hartmann at the Center for Molecular Biology in Heidelberg, Germany, proposed that Aβ42 promotes...
Pilot Study Shows Promise of Passive Immunotherapy
A new approach to immunotherapy for Alzheimer disease (AD) took center stage Tuesday afternoon at the American Academy of Neurology meeting in Miami...
Current Filters
- Date Range : All x